LaCell Overview

  • Founded
  • 2010
  • Status
  • Acquired/​Merged
  • Employees
  • 6
  • Latest Deal Type
  • M&A

LaCell General Information


Producer of stem cells intended for academic and biotechnology research. The company focuses on the production of premium quality stem cells for scientific investigators to facilitate the clinical translation and regulatory approval or stem cells as regenerative therapies, enabling the academic and biotechnology research community to access stem cells.

Contact Information

Ownership Status
Financing Status
Formerly Private Debt Financed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2000 Lakeshore Drive
  • Suite 4020
  • New Orleans, LA 70148
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LaCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2020 0000 Completed Generating Revenue
1. Debt - General 08-Mar-2015 0000 0000 Completed Startup
To view LaCell’s complete valuation and funding history, request access »

LaCell Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial